128 related articles for article (PubMed ID: 19665771)
1. Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.
Somech R; Lai YH; Grunebaum E; Le Saux N; Cutz E; Roifman CM
J Allergy Clin Immunol; 2009 Oct; 124(4):848-50. PubMed ID: 19665771
[No Abstract] [Full Text] [Related]
2. Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).
Hershfield MS
Immunodeficiency; 1993; 4(1-4):93-7. PubMed ID: 8167743
[No Abstract] [Full Text] [Related]
3. Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.
Bory C; Boulieu R; Souillet G; Chantin C; Guibaud P; Hershfield MS
Adv Exp Med Biol; 1991; 309A():173-6. PubMed ID: 1789201
[No Abstract] [Full Text] [Related]
4. Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.
Husain M; Grunebaum E; Naqvi A; Atkinson A; Ngan BY; Aiuti A; Roifman CM
J Pediatr; 2007 Jul; 151(1):93-5. PubMed ID: 17586199
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
Chan B; Wara D; Bastian J; Hershfield MS; Bohnsack J; Azen CG; Parkman R; Weinberg K; Kohn DB
Clin Immunol; 2005 Nov; 117(2):133-43. PubMed ID: 16112907
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy.
Hershfield MS; Chaffee S; Sorensen RU
Pediatr Res; 1993 Jan; 33(1 Suppl):S42-7; discussion S47-8. PubMed ID: 8433874
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
Weinberg K; Hershfield MS; Bastian J; Kohn D; Sender L; Parkman R; Lenarsky C
J Clin Invest; 1993 Aug; 92(2):596-602. PubMed ID: 8349799
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol].
Girault D; Le Deist F; Debré M; Pérignon JL; Herbelin C; Griscelli C; Sciudery D; Hershfield M; Fischer A
Arch Fr Pediatr; 1992 Apr; 49(4):339-43. PubMed ID: 1497422
[TBL] [Abstract][Full Text] [Related]
9. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
Bax BE; Bain MD; Fairbanks LD; Webster AD; Ind PW; Hershfield MS; Chalmers RA
Eur J Haematol; 2007 Oct; 79(4):338-48. PubMed ID: 17680812
[TBL] [Abstract][Full Text] [Related]
10. The entrapment of polyethylene glycol-bound adenosine deaminase (Pegademase) in human carrier erythrocytes.
Bax BE; Fairbanks LD; Bain MD; Simmonds HA; Chalmers RA
Biochem Soc Trans; 1996 Aug; 24(3):442S. PubMed ID: 8878986
[No Abstract] [Full Text] [Related]
11. Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID).
Chakravarti VS; Borns P; Lobell J; Douglas SD
Pediatr Radiol; 1991; 21(6):447-8. PubMed ID: 1749685
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
Hershfield MS; Buckley RH; Greenberg ML; Melton AL; Schiff R; Hatem C; Kurtzberg J; Markert ML; Kobayashi RH; Kobayashi AL
N Engl J Med; 1987 Mar; 316(10):589-96. PubMed ID: 3807953
[TBL] [Abstract][Full Text] [Related]
13. Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.
Notarangelo LD; Stoppoloni G; Toraldo R; Mazzolari E; Coletta A; Airò P; Bordignon C; Ugazio AG
Eur J Pediatr; 1992 Nov; 151(11):811-4. PubMed ID: 1468454
[TBL] [Abstract][Full Text] [Related]
14. Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
Kaufman DA; Hershfield MS; Bocchini JA; Moissidis IJ; Jeroudi M; Bahna SL
Pediatrics; 2005 Dec; 116(6):e876-9. PubMed ID: 16263974
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase.
Bax BE; Bain MD; Fairbanks LD; Webster AD; Chalmers RA
Br J Haematol; 2000 Jun; 109(3):549-54. PubMed ID: 10886203
[TBL] [Abstract][Full Text] [Related]
16. Effects of enzyme replacement therapy on immune function in ADA deficiency patient.
Nakazawa Y; Kawai T; Uchiyama T; Goto F; Watanabe N; Maekawa T; Ishiguro A; Okuyama T; Otsu M; Yamada M; Hershfield MS; Ariga T; Onodera M
Clin Immunol; 2015 Dec; 161(2):391-3. PubMed ID: 26122173
[No Abstract] [Full Text] [Related]
17. The importance of adenosine deaminase for lymphocyte development and function.
Aldrich MB; Blackburn MR; Kellems RE
Biochem Biophys Res Commun; 2000 Jun; 272(2):311-5. PubMed ID: 10833410
[TBL] [Abstract][Full Text] [Related]
18. A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.
Tartibi HM; Hershfield MS; Bahna SL
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26684479
[TBL] [Abstract][Full Text] [Related]
19. Food allergy in a patient with adenosine deaminase deficiency undergoing enzyme replacement with polyethylene glycol-modified adenosine deaminase.
Sicherer SH; Bollinger ME; Hershfield MS; Sampson HA; Lederman HM
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):561-2. PubMed ID: 9564814
[No Abstract] [Full Text] [Related]
20. Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.
Bollinger ME; Arredondo-Vega FX; Santisteban I; Schwarz K; Hershfield MS; Lederman HM
N Engl J Med; 1996 May; 334(21):1367-71. PubMed ID: 8614422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
